View Cart (0)
Menu
Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction

Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction

View Post
EitC Teams Up With AstraZeneca To Launch England’s First Community-Based Heart And Lung Screening Hub

EitC Teams Up With AstraZeneca To Launch England’s First Community-Based Heart And Lung Screening Hub

View Post
Pumping Marvellous Foundation statement and response to the Observer article dated 23rd July 2023

Pumping Marvellous Foundation statement and response to the Observer article dated 23rd July 2023

View Post
National Cardiac Audit Programme: 2023 Annual Report for Patients, Carers and the Public

National Cardiac Audit Programme: 2023 Annual Report for Patients, Carers and the Public

View Post
Urgent action required to rebuild echo workforce

Urgent action required to rebuild echo workforce

View Post
Dance your way to a healthier heart for Eurovision

Dance your way to a healthier heart for Eurovision

View Post
Have a heart and dance to the Eurovision BEATie!

Have a heart and dance to the Eurovision BEATie!

View Post
NICE Chronic Heart Failure in Adults Quality Standard

NICE Chronic Heart Failure in Adults Quality Standard

View Post
Why self-management is key to a better life for heart failure patients

Why self-management is key to a better life for heart failure patients

View Post
Putting patients at the heart of heart failure services

Putting patients at the heart of heart failure services

View Post
MPs more interested in potholes than heart failure

MPs more interested in potholes than heart failure

View Post

Don't miss out

Sign up to our newsletter and get all the latest industry information on Events, Sales and Offers

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
We use cookies to ensure that we give you the best experience on our website. See our privacy-policy for more details.
Donate